<?xml version="1.0"?>
<?xml-stylesheet type="text/css" href="http://www.feuxdelamour.com/v4/skins/common/feed.css?303"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="fr">
		<id>http://www.feuxdelamour.com/v4/index.php?action=history&amp;feed=atom&amp;title=Fast_Fixes_For_LY294002_Troubles</id>
		<title>Fast Fixes For LY294002 Troubles - Historique des versions</title>
		<link rel="self" type="application/atom+xml" href="http://www.feuxdelamour.com/v4/index.php?action=history&amp;feed=atom&amp;title=Fast_Fixes_For_LY294002_Troubles"/>
		<link rel="alternate" type="text/html" href="http://www.feuxdelamour.com/v4/index.php?title=Fast_Fixes_For_LY294002_Troubles&amp;action=history"/>
		<updated>2026-04-10T13:46:32Z</updated>
		<subtitle>Historique pour cette page sur le wiki</subtitle>
		<generator>MediaWiki 1.20alpha</generator>

	<entry>
		<id>http://www.feuxdelamour.com/v4/index.php?title=Fast_Fixes_For_LY294002_Troubles&amp;diff=89443&amp;oldid=prev</id>
		<title>Angle3oil : Page créée avec « The RNaseq data generated by the TCGA Research Network (http://cancergenome.nih.gov/) showed a significant correlation between the expression of both genes (Figure?6A). In... »</title>
		<link rel="alternate" type="text/html" href="http://www.feuxdelamour.com/v4/index.php?title=Fast_Fixes_For_LY294002_Troubles&amp;diff=89443&amp;oldid=prev"/>
				<updated>2017-04-12T06:54:31Z</updated>
		
		<summary type="html">&lt;p&gt;Page créée avec « The RNaseq data generated by the TCGA Research Network (http://cancergenome.nih.gov/) showed a significant correlation between the expression of both genes (Figure?6A). In... »&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Nouvelle page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;The RNaseq data generated by the TCGA Research Network (http://cancergenome.nih.gov/) showed a significant correlation between the expression of both genes (Figure?6A). Interestingly, the silencing of AXL in two MES GSC lines (83 and 1123) decreased the mRNA expression of CD44 (Figure?6B), suggesting a co-regulation of both genes. These data were confirmed at the protein level by immunofluorescent staining of orthotopically [http://www.selleckchem.com/products/LY294002.html see more] injected 83 GSCs transduced with shNT or shRNA targeting AXL (shAXL#2) (Figure?6C). Supporting this finding, in orthotopically xenografted tumors derived from patient GSCs, AXL co-expressed with CD44 preferentially in perinecrotic pseudopallisading areas (Figure?S5). Moreover, AXL and CD44 co-expression correlated with the clinical survival time of glioma patients. The data generated by TCGA Research Network, visualized using the GBM-Bio Discovery Portal, shows that the co-upregulation of AXL and CD44 is a predictor of poor survival in GBM patients (Figure?7A). Figure?6 AXL Expression Correlates with CD44 Figure?7 AXL Is Highly Expressed in Clinical High-Grade Glioma Tumors Finally, we assessed the relevance of AXL as a potential therapeutic target for GBM and other tumor entities. Evaluating the Sun et?al. (2006) dataset, elevated AXL expression was observed in glioma compared with non-tumor (n?= 23 non-tumor group; n?= 7 grade II astrocytoma; n?= 19 grade [http://en.wikipedia.org/wiki/Ribosomal_s6_kinase S6 Kinase] III astrocytoma; n?= 81 GBM group; p?[http://www.selleckchem.com/products/Lapatinib-Ditosylate.html Lapatinib ic50] and p?&lt;/div&gt;</summary>
		<author><name>Angle3oil</name></author>	</entry>

	</feed>